La Jolla, CA, United States of America

Maurizio Sollazzo


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1996-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Maurizio Sollazzo: Innovator in Antigenized Antibodies

Introduction

Maurizio Sollazzo is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of biotechnology, particularly in the development of antigenized antibodies and DNA molecules. With a total of 2 patents, his work has the potential to impact medical research and therapeutic applications.

Latest Patents

Sollazzo's latest patents focus on DNA molecules, expression vectors, and host cells that express antigenized DNA molecules. These innovations include recombinant host cells and processes for preparing antigenized antibodies. His patents describe antibodies that have been recombinantly produced, containing the NANP tetrapeptide of Plasmodium falciparum within their third complementarity determining region. These antibodies are designed to elicit a robust antibody response, showcasing Sollazzo's commitment to advancing immunological research.

Career Highlights

Throughout his career, Maurizio Sollazzo has worked with esteemed institutions, including the University of California. His research has contributed to the understanding of antigenic epitopes and their applications in immunotherapy. His innovative approach to antibody design has garnered attention in the scientific community.

Collaborations

Sollazzo has collaborated with notable professionals in his field, including Maurizio Zanetti. Their joint efforts have furthered research in the development of effective immunological treatments.

Conclusion

Maurizio Sollazzo's work in the field of biotechnology, particularly in antigenized antibodies and DNA molecules, highlights his innovative spirit and dedication to advancing medical science. His contributions are paving the way for future breakthroughs in immunotherapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…